日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Tucidinostat Plus R-CHOP vs R-CHOP in MYC/BCL2 Double-Expressor Diffuse Large B-Cell Lymphoma: A Randomized Clinical Trial

Tucidinostat Plus R-CHOP vs R-CHOP 治疗 MYC/BCL2 双表达弥漫性大 B 细胞淋巴瘤:一项随机临床试验

Xu, Peng-Peng; Song, Yu-Qin; Shen, Jian-Zhen; Cai, Qing-Qing; Zhou, Hui; Zhang, Li-Ling; Xiang, Ying; Sun, Xiu-Hua; Yang, Wei; Yao, Zhi-Hua; Jing, Hong-Mei; Wen, Shu-Juan; Jin, Jie; Xue, Hong-Wei; Cen, Hong; Ding, Kai-Yang; Jin, Zheng-Ming; Liu, Li-Hong; Xing, Xiao-Jing; Li, Lan-Fang; Hou, Ming; Liu, Lin; Zhang, Ming-Zhi; Li, Wen-Yu; Bai, Ou; Feng, Ru; Zhu, Zun-Min; Wu, Hui-Jing; Su, Li-Ping; Gao, Li; Li, Fei; Huang, Wen-Rong; Liu, Peng; Yan, Xiao-Jing; Zhao, Ying; Su, Hang; Zhao, Xie-Lan; Fu, Rong; Liu, Hong; Shi, Wen-Yu; Li, Hui-Zhi; Chen, Bo; Ning, Zhi-Qiang; Zhu, Jun; Zhao, Wei-Li

Treatment of Follicular Lymphoma With CHOP and Anti-CD20 Therapy: 15-Year Follow-Up of the SWOG S0016 Trial

采用 CHOP 方案联合抗 CD20 疗法治疗滤泡性淋巴瘤:SWOG S0016 试验的 15 年随访

Shadman, Mazyar; LeBlanc, Michael; Rimsza, Lisa; Leonard, John P; Smith, Sonali M; Li, Hongli; Friedberg, Jonathan W

ctDNA dynamics demonstrates rapid treatment response to tafasitamab + R-CHOP +/- lenalidomide and predicts outcome in diffuse large B-cell lymphoma: results from the phase 1b First-MIND study

ctDNA动态变化显示,tafasitamab + R-CHOP +/- 来那度胺治疗可快速改善弥漫性大B细胞淋巴瘤的预后:来自1b期First-MIND研究的结果

Khouja, Mouhamad; Kehden, Britta; Blair, Derek; Kuffer, Christian; Wagner, Steve; Versteegen, Tim; Nakov, Philipp; Brüggemann, Monika; Baldus, Claudia; Belada, David; Nowakowski, Grzegorz S; Schilhabel, Anke; Darzentas, Nikos; Pott, Christiane

Retreatment with R-CHOP-like therapy in patients with late relapse of diffuse large B-cell lymphoma

对晚期复发的弥漫性大B细胞淋巴瘤患者采用R-CHOP样疗法进行再治疗

Champagne, Jean-Nicolas; Villa, Diego; Gerrie, Alina S; Venner, Christopher P; Slack, Graham W; Farinha, Pedro; Craig, Jeffrey W; Hilton, Laura K; Savage, Kerry J; Scott, David W; Sehn, Laurie H

Impact of Perforin 1 A91V germ line background in patients with aggressive B-NHL treated with R-CHOP

穿孔素1 A91V种系背景对接受R-CHOP方案治疗的侵袭性B细胞非霍奇金淋巴瘤患者的影响

Cetin, Onur; Kos, Igor; Regitz, Evi; Bewarder, Moritz; Rixecker, Torben M; Tausch, Eugen; Schwarz, Eva C; Jansky, Johanna; Lesan, Vadim; Schormann, Claudia; Neumann, Frank; Loeffler, Markus; Hallek, Michael; Fischer, Kirsten; Zöphel, Sylvia; Staiger, Annette M; Ott, German; Christofyllakis, Konstantinos; Bittenbring, Joerg T; Poeschel, Viola; Kaddu-Mulindwa, Dominic; Staber, Philipp B; Ligtvoet, Rudy; Robrecht, Sandra; Ziepert, Marita; Schmitz, Norbert; Hoth, Markus; Kessel, Christoph; Stilgenbauer, Stephan; Altmann, Bettina; Thurner, Lorenz

ENDOU-1-induced cytoplasmic HnRNPA3 recognizes m6A methylation on the upstream reading frame of human CHOP transcripts to achieve maximal CHOP translation.

ENDOU-1 诱导的细胞质 HnRNPA3 识别人类 CHOP 转录本上游阅读框上的 m6A 甲基化,从而实现 CHOP 的最大翻译。

Lee Hung-Chieh, Huang Yi-Hsin, Hsieh Chi-Cheng, Ke Yi-Nan, Tsai Huai-Jen

Mechanism by which SAHA regulates HLA-E expression via the endoplasmic reticulum stress-related PERK/ATF4/CHOP pathway in neuroblastoma

SAHA通过内质网应激相关的PERK/ATF4/CHOP通路调控神经母细胞瘤中HLA-E表达的机制

Li, Zhuoran; Zhen, Xi; Zeng, Chenggong; Mao, Yan; Wei, Zhiqing; Zhen, Zijun

Real-World Data of R-mini-CHOP Therapy in Elderly Hispanic Population with Diffuse Large B-Cell Lymphoma and High-Grade Follicular Lymphoma

R-mini-CHOP 疗法在老年西班牙裔弥漫性大B细胞淋巴瘤和高级别滤泡性淋巴瘤患者中的真实世界数据

Romagnoli, Carla; Guerra, Veronica; Santos-Carrion, Leily; Ocampo, Marisol; Lyubimova, Alexandra; Goya Balaguer, Evelyn; Brauchle, Yelida; Gligich, Oleg; Bastos, Bruno; Simkins, Aron; Blaustein, Arnold; Schwartz, Michael; Cusnir, Mike; Barrientos, Jacqueline C

LPS-TLR4 signaling attenuates CHOP-mediated apoptosis under endoplasmic reticulum stress conditions during porcine embryonic development.

在猪胚胎发育过程中,LPS-TLR4 信号传导可减弱内质网应激条件下 CHOP 介导的细胞凋亡。

MSMO1 promotes chemotherapy resistance through modulation of T-MAS metabolism via PERK/elF2α/ATF4/CHOP pathway

MSMO1通过PERK/eIF2α/ATF4/CHOP通路调控T-MAS代谢,从而促进化疗耐药。

Ren, Hengyu; Wang, Xuliren; Shao, Zhibo; Xiong, Min; Chi, Weiru; Sang, Yuting; Zhang, Qi; Wang, Zehao; Liu, Douwaner; Zhang, Liyi; Chen, Ming; Zhu, Han; Xue, Jingyan; Xiu, Bingqiu; Chi, Yayun; Wu, Jiong